Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
C R Yang, G J Mogenso. Hippocampal signal transmission to the pedunculopontine nucleus and its regulation by dopamine D2 receptors in the nucleus accumbens: an electrophysiological and behavioural study. Neuroscience. vol 23. issue 3. 1988-04-05. PMID:2963972. |
signal transmission from the hippocampus may be regulated by a dopamine d2 receptor mechanism in the accumbens, presumably mediated by the converging mesolimbic dopaminergic input from the ventral tegmental area. |
1988-04-05 |
2023-08-11 |
rat |
L A DuMars, L D Rodger, P W Kaliva. Behavioral cross-sensitization between cocaine and enkephalin in the A10 dopamine region. Behavioural brain research. vol 27. issue 1. 1988-04-05. PMID:3342116. |
the motor stimulant effect produced by cocaine and the injection of opioids onto a10 dopamine neurons is thought to be mediated by an increase in dopaminergic transmission in mesolimbic dopamine terminal fields such as the nucleus accumbens. |
1988-04-05 |
2023-08-11 |
rat |
G Robuschi, M Montermini, P Chiodera, E Gardini, M Salvi, A Alboni, E Borciani, A Gnudi, E Rot. Dopaminergic regulation of fetal growth hormone (GH) secretion: study with maternal administration of bromocriptine. Journal of perinatal medicine. vol 15. issue 4. 1988-03-30. PMID:3437376. |
to investigate the role of dopaminergic pathways on the control of growth hormone (gh) secretion, bromocriptine (bmc), a dopamine agonist drug, was orally administered at the dose of 5 mg to 46 pregnant women during labor whereas 41 received placebo. |
1988-03-30 |
2023-08-11 |
Not clear |
J W Gibb, D M Stone, D C Stahl, G R Hanso. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain. NIDA research monograph. vol 76. 1988-03-29. PMID:2449619. |
in contrast to meth, which induced pronounced deficits in dopaminergic neuronal markers, repeated doses of mda or mdma did not alter striatal tyrosine hydroxylase (th) activities or reduce striatal dopamine concentrations. |
1988-03-29 |
2023-08-11 |
rat |
N Panagopoulos, N A Matsokis, T Valcan. Kinetic and pharmacologic characterization of dopamine binding in the mouse cerebellum and the effects of the reeler mutation. Journal of neuroscience research. vol 19. issue 1. 1988-03-25. PMID:3343704. |
the purpose of this study was to characterize the dopaminergic system in the mouse cerebellum and to determine whether the dyskinesia of the reeler mutant is accompanied by alterations in cerebellar and/or striatal dopamine binding. |
1988-03-25 |
2023-08-11 |
mouse |
N Panagopoulos, N A Matsokis, T Valcan. Kinetic and pharmacologic characterization of dopamine binding in the mouse cerebellum and the effects of the reeler mutation. Journal of neuroscience research. vol 19. issue 1. 1988-03-25. PMID:3343704. |
from the analysis of (3h) dopamine ((3h)da) and (3h)spiperone ((3h)sp) binding, the study of the effects of several drugs on this binding, and the comparison of these parameters between the cerebellum and striatum, we conclude that a dopaminergic system exists in the cerebellum with properties common to the striatal system but also with some differences. |
1988-03-25 |
2023-08-11 |
mouse |
H Eriksson, K Mägiste, L O Plantin, F Fonnum, K G Hedström, E Theodorsson-Norheim, K Kristensson, E Stålberg, E Heilbron. Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation. Archives of toxicology. vol 61. issue 1. 1988-03-25. PMID:3439874. |
our data suggest a reduction in number of dopaminergic nerve terminals, as the activity of the dopamine synthesizing enzyme dopa-decarboxylase was also lowered. |
1988-03-25 |
2023-08-11 |
human |
P Kontr. Interactions of taurine and dopamine in the striatum. Advances in experimental medicine and biology. vol 217. 1988-03-22. PMID:3434428. |
both spontaneous and k+-stimulated taurine release from rat striatal slices were affected by dopamine and apomorphine, suggesting that dopaminergic systems are able to modulate taurine release. |
1988-03-22 |
2023-08-11 |
rat |
B P Draye. Imaging of the aging brain. Part II. Pathologic conditions. Radiology. vol 166. issue 3. 1988-03-16. PMID:3277248. |
parkinsonian disorders are characterized by generalized brain atrophy and dopaminergic site (e.g., putamen, pars compacta of the substantia nigra) iron or pigmentary accumulation best visualized in disease that responds poorly to dopamine replacement therapy. |
1988-03-16 |
2023-08-11 |
Not clear |
C C Mermet, F G Gono. Ether stress stimulates noradrenaline release in the hypothalamic paraventricular nucleus. Neuroendocrinology. vol 47. issue 1. 1988-03-15. PMID:3340273. |
this effect appeared specific for noradrenergic terminals, since no effect on dopamine release was observed when recorded from the striatum or behind the paraventricular hypothalamic nucleus from the a13 dopaminergic group. |
1988-03-15 |
2023-08-11 |
rat |
O Iimura, I Yamaji, K Kikuchi, S Shibata, M Nishimura, A Nozawa, K Aoki, T Hasegawa, H Kobayakawa, H Komur. The pathophysiological role of renal dopaminergic activity in patients with essential hypertension. Japanese circulation journal. vol 51. issue 10. 1988-03-07. PMID:3323560. |
to evaluate the role of the renal dopaminergic system on renal water-sodium metabolism patients with essential hypertension (eht), urinary excretion of dopamine, urinary excretion of sodium (unav) and fractional excretion of sodium (fena) were all investigated before and after the administration of dopamine (3 micrograms/kg/min, intravenous infusion for 60 minutes), dopamine antagonist, metoclopramide (8 mg/m2 bsa, intravenous injection) or mild sodium loading in both normotensive subjects and benign eht. |
1988-03-07 |
2023-08-11 |
human |
S Sat. [The properties of prolactin secretion in patients with prolactin secreting pituitary adenomas]. Nihon Naibunpi Gakkai zasshi. vol 63. issue 8. 1988-03-04. PMID:3123284. |
the plasma prl responses to dopaminergic agents (l-dopa, cb-154, dopamine) were greater in responders than in non-responders (% of basal: l-dopa, 33.7 +/- 3.7% vs 51.6 +/- 5.6% at 150 min, p less than 0.05; cb-154, 16.5 +/- 2.6% vs 30.9 +/- 2.8% at 6 hr, p less than 0.05; dopamine, 31.7 +/- 5.6% vs 44.9 +/- 4.3% at 90 min, p less than 0.05). |
1988-03-04 |
2023-08-11 |
human |
G E Meredith, W J Smeet. Immunocytochemical analysis of the dopamine system in the forebrain and midbrain of Raja radiata: evidence for a substantia nigra and ventral tegmental area in cartilaginous fish. The Journal of comparative neurology. vol 265. issue 4. 1988-02-26. PMID:3429712. |
dopamine immunoreactive fibers are found in the glomeruli of the olfactory bulbs, in ventral portions of the telencephalon, where a dense dopaminergic plexus innervates the area superficialis basalis and striatum, and in the diencephalon, where the inferior lobe is the most densely innervated structure. |
1988-02-26 |
2023-08-11 |
Not clear |
A Parent, Y Smit. Differential dopaminergic innervation of the two pallidal segments in the squirrel monkey (Saimiri sciureus). Brain research. vol 426. issue 2. 1988-02-20. PMID:2891410. |
this innervation derived mostly from two fascicles that detached themselves from the major ascending dopaminergic bundle arising from midbrain dopamine cell bodies and running in the lateral hypothalamus. |
1988-02-20 |
2023-08-11 |
squirrel_monkey |
R A Wis. The role of reward pathways in the development of drug dependence. Pharmacology & therapeutics. vol 35. issue 1-2. 1988-02-20. PMID:3321101. |
benzodiazepines and barbiturates stimulate locomotor activity without stimulating dopamine turnover; they may interact with reward pathways at a synapse efferent to the dopaminergic link in the pathways. |
1988-02-20 |
2023-08-11 |
Not clear |
R M Shapiro, N A Camarota, S D Glic. Nocturnal rotational behavior in rats: further neurochemical support for a two-population model. Brain research bulletin. vol 19. issue 4. 1988-02-17. PMID:2446719. |
these results are identical to those we previously reported using the vmax for dopamine uptake in vitro as the measure for striatal dopaminergic innervation. |
1988-02-17 |
2023-08-11 |
rat |
R Sandyk, M Bergsneider, R P Iacon. Acute psychosis in a woman with a prolactinoma. The International journal of neuroscience. vol 37. issue 3-4. 1988-02-17. PMID:3692700. |
serum prolactin levels fell approximately four months prior to onset of the psychotic episode and thus may have provided a predictive indicator of changing dopamine activity in both the tubero-infundibular and the mesolimbic-mesocortical dopaminergic systems. |
1988-02-17 |
2023-08-11 |
Not clear |
A M Garrigues, F Gehelmann, J M Girault, M Delaage, J Labouess. Haloperidol-succinylglycyl[125I]iodotyrosine, a novel iodinated ligand for dopamine D2 receptors. FEBS letters. vol 224. issue 2. 1988-02-12. PMID:3691792. |
its pharmacology, determined by competitive displacement with dopaminergic and non-dopaminergic drugs, is characteristic of binding to dopamine d2 receptors. |
1988-02-12 |
2023-08-11 |
cattle |
J Grässler, C Wustmann, H D Fischer, J Schmidt, D W Scheuc. Inhibition of stimulated dopamine release from striatum slices after hemorrhagic shock in the rat. Protective effect of piracetam. Methods and findings in experimental and clinical pharmacology. vol 9. issue 8. 1988-01-28. PMID:3695732. |
hemorrhagic shock caused an inhibition of k+ induced dopamine release from striatum slices in proportion to the magnitude of hemorrhage, reflecting the degree of membrane damage in dopaminergic transmission structures. |
1988-01-28 |
2023-08-11 |
rat |
D G Daniel, A Swallows, F Wolf. Capgras delusion and seizures in association with therapeutic dosages of disulfiram. Southern medical journal. vol 80. issue 12. 1988-01-25. PMID:3423903. |
that disulfiram has been shown to inhibit dopamine beta-hydroxylase in vitro suggests an etiologic role for dopaminergic pathways in at least some cases of capgras syndrome. |
1988-01-25 |
2023-08-11 |
Not clear |